002166 莱茵生物
交易中 04-30 14:54:33
资讯
新帖
简况
图解莱茵生物一季报：第一季度单季净利润同比增长38.06%
证券之星 · 03:09
图解莱茵生物一季报：第一季度单季净利润同比增长38.06%
莱茵生物（002166）披露2025年度股东会决议公告，4月27日股价下跌0.12%
证券之星 · 04-27 18:44
莱茵生物（002166）披露2025年度股东会决议公告，4月27日股价下跌0.12%
莱茵生物：公司主营天然健康功能性成分的研发与生产
证券之星 · 04-21
莱茵生物：公司主营天然健康功能性成分的研发与生产
莱茵生物（002166）披露股东部分股份解除质押公告，4月20日股价上涨0.22%
证券之星 · 04-20
莱茵生物（002166）披露股东部分股份解除质押公告，4月20日股价上涨0.22%
莱茵生物（002166）披露2025年度网上业绩说明会安排，4月07日股价上涨1.0%
证券之星 · 04-07
莱茵生物（002166）披露2025年度网上业绩说明会安排，4月07日股价上涨1.0%
图解莱茵生物年报：第四季度单季净利润同比增长18.48%
证券之星 · 03-31
图解莱茵生物年报：第四季度单季净利润同比增长18.48%
股市必读：莱茵生物（002166）3月23日收盘跌8.17%，主力净流入1221.4万元
证券之星 · 03-24
股市必读：莱茵生物（002166）3月23日收盘跌8.17%，主力净流入1221.4万元
莱茵生物（002166）披露股东部分股份解除质押公告，3月4日股价下跌0.23%
证券之星 · 03-04
莱茵生物（002166）披露股东部分股份解除质押公告，3月4日股价下跌0.23%
莱茵生物（002166）披露控制权变更及发行股份购买资产事项进展公告，2月24日股价上涨1.81%
证券之星 · 02-24
莱茵生物（002166）披露控制权变更及发行股份购买资产事项进展公告，2月24日股价上涨1.81%
异动快报：莱茵生物（002166）1月26日13点23分触及涨停板
证券之星 · 01-26
异动快报：莱茵生物（002166）1月26日13点23分触及涨停板
莱茵生物（002166）披露控制权变更及发行股份购买资产事项进展公告，1月23日股价上涨0.67%
证券之星 · 01-23
莱茵生物（002166）披露控制权变更及发行股份购买资产事项进展公告，1月23日股价上涨0.67%
莱茵生物（002166）披露股东部分股份质押延期购回，1月19日股价下跌0.66%
证券之星 · 01-19
莱茵生物（002166）披露股东部分股份质押延期购回，1月19日股价下跌0.66%
莱茵生物：莽草酸为奥司他韦原料之一
证券之星 · 01-07
莱茵生物：莽草酸为奥司他韦原料之一
莱茵生物（002166）披露股东部分股份解除质押及再质押公告，1月6日股价下跌0.12%
证券之星 · 01-06
莱茵生物（002166）披露股东部分股份解除质押及再质押公告，1月6日股价下跌0.12%
莱茵生物：美国基地保留CBD产线
证券之星 · 2025-12-26
莱茵生物：美国基地保留CBD产线
股市必读：莱茵生物（002166）登12月25日交易所龙虎榜
证券之星 · 2025-12-26
股市必读：莱茵生物（002166）登12月25日交易所龙虎榜
莱茵生物最新公告：控股股东将变更为广州德福营养股票明起复牌
证券之星 · 2025-12-23
莱茵生物最新公告：控股股东将变更为广州德福营养股票明起复牌
莱茵生物：公司主营业务不会发生变化
证券之星 · 2025-12-17
莱茵生物：公司主营业务不会发生变化
莱茵生物：植物提取产能充足
证券之星 · 2025-12-10
莱茵生物：植物提取产能充足
莱茵生物(002166.SZ)控制权或将易手 12月10日起停牌
智通财经 · 2025-12-09
莱茵生物(002166.SZ)控制权或将易手 12月10日起停牌
加载更多
公司概况
公司名称：
桂林莱茵生物科技股份有限公司
所属行业：
医药制造业
上市日期：
2007-09-13
主营业务：
桂林莱茵生物科技股份有限公司的主营业务是植物功能性成分的研发与生产。公司的主要产品是罗汉果提取物、甜叶菊提取物、茶叶提取物及其他植物提取物，瑞鲍迪苷RM2及甜菊糖苷RM系列产品、左旋β-半乳葡聚糖等。
发行价格：
9.89
{"stockData":{"symbol":"002166","market":"SZ","secType":"STK","nameCN":"莱茵生物","latestPrice":8.76,"timestamp":1777532073000,"preClose":8.59,"halted":0,"volume":10161405,"delay":0,"changeRate":0.0198,"floatShares":739000000,"shares":742000000,"eps":0.1662,"marketStatus":"交易中","change":0.17,"latestTime":"04-30 14:54:33","open":8.76,"high":8.8,"low":8.69,"amount":88979800,"amplitude":0.0128,"askPrice":8.77,"askSize":988,"bidPrice":8.76,"bidSize":9,"shortable":0,"etf":0,"ttmEps":0.1662,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1777532400000},"marketStatusCode":2,"adr":0,"adjPreClose":8.59,"symbolType":"stock","openAndCloseTimeList":[[1777512600000,1777519800000],[1777525200000,1777532400000]],"highLimit":9.45,"lowLimit":7.73,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":741609425,"isCdr":false,"pbRate":2.02,"roa":"--","peRate":52.707581,"roe":"1.34%","epsLYR":0.1945,"committee":-0.365646,"marketValue":6496000000,"turnoverRate":0.0138,"status":0,"floatMarketCap":6470000000},"requestUrl":"/m/hq/s/002166","defaultTab":"news","newsList":[{"id":"2631528985","title":"图解莱茵生物一季报：第一季度单季净利润同比增长38.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631528985","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631528985?lang=zh_cn&edition=full","pubTime":"2026-04-30 03:09","pubTimestamp":1777489790,"startTime":"0","endTime":"0","summary":"证券之星消息，莱茵生物2026年一季报显示，一季度公司主营收入4.47亿元，同比上升0.58%；归母净利润4251.65万元，同比上升38.06%；扣非净利润4032.82万元，同比上升11.6%；负债率36.17%，投资收益5.27万元，财务费用1367.88万元，毛利率23.72%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000008888.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002166"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630360121","title":"莱茵生物（002166）披露2025年度股东会决议公告，4月27日股价下跌0.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630360121","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630360121?lang=zh_cn&edition=full","pubTime":"2026-04-27 18:44","pubTimestamp":1777286640,"startTime":"0","endTime":"0","summary":"截至2026年4月27日收盘，莱茵生物报收于8.64元，较前一交易日下跌0.12%，最新总市值为64.08亿元。该股当日开盘8.58元，最高8.67元，最低8.48元，成交额达7310.6万元，换手率为1.16%。公司于近日披露《2025年度股东会决议公告》。会议采取现场投票与网络投票相结合的方式进行，表决结果均为通过，无否决提案情形。北京德恒律师事务所对本次会议出具法律意见，认为会议召集、召开程序及表决结果合法有效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700035270.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0168","BK0028","BK0174","002166","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629088987","title":"莱茵生物：公司主营天然健康功能性成分的研发与生产","url":"https://stock-news.laohu8.com/highlight/detail?id=2629088987","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629088987?lang=zh_cn&edition=full","pubTime":"2026-04-21 15:03","pubTimestamp":1776754995,"startTime":"0","endTime":"0","summary":"证券之星消息，莱茵生物04月21日在投资者关系平台上答复投资者关心的问题。非常感谢您对公司的关注。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042100029294.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","002166","BK0028","BK0168","BK0239","BK0174"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628874958","title":"莱茵生物（002166）披露股东部分股份解除质押公告，4月20日股价上涨0.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628874958","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628874958?lang=zh_cn&edition=full","pubTime":"2026-04-20 17:47","pubTimestamp":1776678468,"startTime":"0","endTime":"0","summary":"莱茵生物于2026年4月20日发布公告称，公司大股东秦本军先生已于2026年4月16日向国海证券股份有限公司偿还全部融资借款，并办理了部分股份解除质押手续。本次解除质押股份2,640.00万股，占其所持公司股份比例9.73%，占公司总股本比例3.56%。截至公告披露日，秦本军先生累计持有公司股份27,138.96万股，持股比例36.59%，累计质押股份7,830.00万股，占其所持股份比例28.85%，占公司总股本比例10.56%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042000025046.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0174","BK0168","BK0046","BK0239","002166"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625599939","title":"莱茵生物（002166）披露2025年度网上业绩说明会安排，4月07日股价上涨1.0%","url":"https://stock-news.laohu8.com/highlight/detail?id=2625599939","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625599939?lang=zh_cn&edition=full","pubTime":"2026-04-07 17:34","pubTimestamp":1775554458,"startTime":"0","endTime":"0","summary":"截至2026年4月7日收盘，莱茵生物报收于9.13元，较前一交易日上涨1.0%，最新总市值为67.71亿元。近日，莱茵生物披露《关于举办2025年度网上业绩说明会的公告》。公告显示，公司已于2026年3月31日在巨潮资讯网披露2025年年度报告。为便于投资者了解公司经营、财务及发展战略情况，公司将于2026年4月9日15:00-16:00通过价值在线平台举行2025年度网上业绩说明会，采用网络文字互动方式与投资者交流。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040700024498.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","002166","BK0168","BK0239","BK0174","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623328009","title":"图解莱茵生物年报：第四季度单季净利润同比增长18.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623328009","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623328009?lang=zh_cn&edition=full","pubTime":"2026-03-31 01:52","pubTimestamp":1774893168,"startTime":"0","endTime":"0","summary":"证券之星消息，莱茵生物2025年年报显示，当年度公司主营收入20.44亿元，同比上升15.36%；归母净利润1.43亿元，同比下降12.2%；扣非净利润1.27亿元，同比下降16.32%；其中2025年第四季度，公司单季度主营收入7.72亿元，同比上升28.23%；单季度归母净利润7272.94万元，同比上升18.48%；单季度扣非净利润6519.64万元，同比上升39.21%；负债率39.8%，投资收益460.05万元，财务费用4384.09万元，毛利率25.75%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026033100004589.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002166"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621085780","title":"股市必读：莱茵生物（002166）3月23日收盘跌8.17%，主力净流入1221.4万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2621085780","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621085780?lang=zh_cn&edition=full","pubTime":"2026-03-24 02:16","pubTimestamp":1774289773,"startTime":"0","endTime":"0","summary":"截至2026年3月23日收盘，莱茵生物报收于8.2元，下跌8.17%，换手率3.83%，成交量28.34万手，成交额2.37亿元。当日关注点来自交易信息汇总：莱茵生物股价连续5日下跌，3月23日收跌8.17%，主力资金当日净流入1221.4万元。公司公告汇总桂林莱茵生物科技股份有限公司于2025年12月22日签署协议，原控股股东秦本军向广州德福营养转让公司8.09%股份，并放弃25.50%股份表决权。截至2026年3月24日，股份转让诚意金已支付，审计、评估、尽职调查等工作正有序推进。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400002064.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0174","BK0168","BK0046","002166","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616564305","title":"莱茵生物（002166）披露股东部分股份解除质押公告，3月4日股价下跌0.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616564305","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616564305?lang=zh_cn&edition=full","pubTime":"2026-03-04 22:14","pubTimestamp":1772633661,"startTime":"0","endTime":"0","summary":"截至2026年3月4日收盘，莱茵生物报收于8.69元，较前一交易日下跌0.23%，最新总市值为64.45亿元。近日，桂林莱茵生物科技股份有限公司发布公告，公司大股东秦本军先生已于2026年3月3日将其持有的6,800.00万股公司股份解除质押，占其所持公司股份比例的25.06%，占公司总股本的9.17%。该部分股份原质押给国海证券，质押起始日为2022年7月28日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030400040146.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0174","BK0046","BK0028","002166","BK0239","BK0168"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613457717","title":"莱茵生物（002166）披露控制权变更及发行股份购买资产事项进展公告，2月24日股价上涨1.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613457717","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613457717?lang=zh_cn&edition=full","pubTime":"2026-02-24 22:13","pubTimestamp":1771942395,"startTime":"0","endTime":"0","summary":"截至2026年2月24日收盘，莱茵生物报收于8.99元，较前一交易日上涨1.81%，最新总市值为66.67亿元。近日，莱茵生物发布《关于公司控制权变更、发行股份购买资产并募集配套资金暨关联交易事项的进展公告》。公告显示，公司于2025年12月22日签署协议，原控股股东秦本军向广州德福营养转让公司8.09%股份，并放弃25.50%股份表决权。本次交易尚需董事会、股东大会审议及监管机构批准。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022400043866.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0174","BK0239","002166","BK0168","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606296630","title":"异动快报：莱茵生物（002166）1月26日13点23分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2606296630","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606296630?lang=zh_cn&edition=full","pubTime":"2026-01-26 13:25","pubTimestamp":1769405126,"startTime":"0","endTime":"0","summary":"证券之星1月26日盘中消息，13点23分莱茵生物触及涨停板。其所属行业化学制品目前下跌。领涨股为乐通股份。该股为流感，合成生物，甜味剂/代糖概念热股，当日流感概念上涨3.02%，合成生物概念上涨0.7%，甜味剂/代糖概念上涨0.22%。1月23日的资金流向数据方面，主力资金净流入15.06万元，占总成交额0.16%，游资资金净流出469.91万元，占总成交额4.85%，散户资金净流入454.85万元，占总成交额4.69%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012600013663.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0046","002166","BK0168","BK0174"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605409275","title":"莱茵生物（002166）披露控制权变更及发行股份购买资产事项进展公告，1月23日股价上涨0.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605409275","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605409275?lang=zh_cn&edition=full","pubTime":"2026-01-23 23:17","pubTimestamp":1769181431,"startTime":"0","endTime":"0","summary":"截至2026年1月23日收盘，莱茵生物报收于9.06元，较前一交易日上涨0.67%，最新总市值为67.19亿元。近日，桂林莱茵生物科技股份有限公司发布《关于公司控制权变更、发行股份购买资产并募集配套资金暨关联交易事项的进展公告》。公告显示，公司于2025年12月22日签署协议，原控股股东秦本军向广州德福营养转让公司8.09%股份，并放弃25.50%股份表决权。截至公告日，股份转让及尽职调查、审计评估等工作正有序推进。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012300043955.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0046","BK0174","BK0239","002166","BK0168"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2604314001","title":"莱茵生物（002166）披露股东部分股份质押延期购回，1月19日股价下跌0.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2604314001","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604314001?lang=zh_cn&edition=full","pubTime":"2026-01-19 22:48","pubTimestamp":1768834093,"startTime":"0","endTime":"0","summary":"截至2026年1月19日收盘，莱茵生物报收于9.03元，较前一交易日下跌0.66%，最新总市值为66.97亿元。近日，莱茵生物发布公告称，公司大股东秦本军将其质押给国海证券的10,170万股股份办理了延期购回，延期后质押到期日为2026年7月16日，质押用途为个人资金需求。截至公告日，秦本军累计质押股份17,270万股，占其所持股份的63.64%，占公司总股本的23.29%。秦本军未来半年内到期的质押股份为14,670万股，对应融资余额9,999万元。其质押股份不存在平仓风险。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011900036072.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","002166","BK0168","BK0028","BK0174","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601825316","title":"莱茵生物：莽草酸为奥司他韦原料之一","url":"https://stock-news.laohu8.com/highlight/detail?id=2601825316","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601825316?lang=zh_cn&edition=full","pubTime":"2026-01-07 11:34","pubTimestamp":1767756881,"startTime":"0","endTime":"0","summary":"证券之星消息，莱茵生物(002166)01月07日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘好，请问新闻报道说美国流感爆发，请问对于公司在美国业务有何影响？莱茵生物回复：您好，公司主要从事天然健康产品的生产经营业务，专注于植物功能性成分的研发与生产，其中莽草酸产品是抗流感药物奥司他韦的生产原料之一，目前该产品销量占公司营收比重较小。公司美国印州工厂聚焦天然甜味剂、部分功能性成分的生产，目前海外业务生产经营正常，敬请投资者注意投资风险。谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010700013856.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0168","BK0028","BK0046","BK0174","002166","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601813992","title":"莱茵生物（002166）披露股东部分股份解除质押及再质押公告，1月6日股价下跌0.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601813992","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601813992?lang=zh_cn&edition=full","pubTime":"2026-01-06 22:22","pubTimestamp":1767709343,"startTime":"0","endTime":"0","summary":"截至2026年1月6日收盘，莱茵生物报收于8.57元，较前一交易日下跌0.12%，最新总市值为63.56亿元。该股当日开盘8.58元，最高8.63元，最低8.52元，成交额达1.31亿元，换手率为2.06%。公司近日发布公告称，大股东秦本军先生近日办理了部分股份解除质押及再质押手续。本次解除质押4,904.44万股，占其所持股份比例18.07%，占公司总股本6.61%。本次质押系为股份转让诚意金提供的担保。公司表示，该事项不涉及新增融资，秦本军不存在平仓风险。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010600042497.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0168","BK0028","BK0239","BK0046","BK0174","002166"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2594261206","title":"莱茵生物：美国基地保留CBD产线","url":"https://stock-news.laohu8.com/highlight/detail?id=2594261206","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594261206?lang=zh_cn&edition=full","pubTime":"2025-12-26 15:06","pubTimestamp":1766732784,"startTime":"0","endTime":"0","summary":"证券之星消息，莱茵生物(002166)12月26日在投资者关系平台上答复投资者关心的问题。投资者提问：医用CBD公司能生产吗，产能是多少，公司有CBD存货，这么长时间还未销售出去，是不合格还是什么原因莱茵生物回复：您好，公司美国印州生产基地已获CGMP认证，2025年实施升级改造后，仍保留部分CBD提取产线，可随时响应市场对于CBD等衍生产品的需求。谢谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f0885ac0c5d9e906055df7ae727a5f25","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122600016416.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0174","BK0239","BK0168","002166","BK0046","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2594258720","title":"股市必读：莱茵生物（002166）登12月25日交易所龙虎榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2594258720","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594258720?lang=zh_cn&edition=full","pubTime":"2025-12-26 01:03","pubTimestamp":1766682196,"startTime":"0","endTime":"0","summary":"截至2025年12月25日收盘，莱茵生物报收于9.43元，下跌1.46%，换手率11.55%，成交量85.45万手，成交额8.29亿元。当日关注点来自交易信息汇总：12月25日主力资金净流出3669.3万元，游资资金净流入3469.73万元。来自龙虎榜上榜：莱茵生物因日振幅值达到15%于12月25日登龙虎榜，为近5个交易日内首次上榜。龙虎榜上榜沪深交易所2025年12月25日公布的交易公开信息显示，莱茵生物因日振幅值达到15%的前5只证券登上龙虎榜。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122600000349.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0168","BK0028","BK0239","BK0046","BK0174","002166"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593418677","title":"莱茵生物最新公告：控股股东将变更为广州德福营养股票明起复牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2593418677","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593418677?lang=zh_cn&edition=full","pubTime":"2025-12-23 21:20","pubTimestamp":1766496011,"startTime":"0","endTime":"0","summary":"莱茵生物公告称，公司控股股东、实际控制人秦本军拟向广州德福营养转让其所持公司6000万股股份，并放弃1.89亿股股份的表决权，保留3.00%的表决权。广州德福营养将成为公司控股股东，侯明和LI ZHENFU将成为公司共同实际控制人。该交易尚需取得深圳证券交易所的合规性确认意见，并经公司董事会再次审议及股东会审议通过，以及深圳证券交易所审核同意及中国证券监督管理委员会注册后方可正式实施。公司股票将于2025年12月24日开市起复牌。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122300038696.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0168","BK0028","BK0174","002166","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2592959025","title":"莱茵生物：公司主营业务不会发生变化","url":"https://stock-news.laohu8.com/highlight/detail?id=2592959025","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592959025?lang=zh_cn&edition=full","pubTime":"2025-12-17 08:57","pubTimestamp":1765933030,"startTime":"0","endTime":"0","summary":"证券之星消息，莱茵生物12月16日在投资者关系平台上答复投资者关心的问题。cbd业务是否已取消？之前成立的几个美国cbd公司目前运营情况？因此，公司主营业务不会发生变化。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121700004588.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0174","BK0028","BK0046","BK0168","BK0239","002166"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2590372234","title":"莱茵生物：植物提取产能充足","url":"https://stock-news.laohu8.com/highlight/detail?id=2590372234","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590372234?lang=zh_cn&edition=full","pubTime":"2025-12-10 11:37","pubTimestamp":1765337825,"startTime":"0","endTime":"0","summary":"证券之星消息，莱茵生物(002166)12月09日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘好。目前看网上报道这次流感是世界范围内的，而且是这几年最严重的一次，公司目前是满产吗？客户需要排队预约吗？莱茵生物回复：您好，公司植物提取产能充足，目前备有一定的莽草酸存货，可随时响应市场需求。谢谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121000014059.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002166","BK0046","BK0174","BK0239","BK0168","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2590101733","title":"莱茵生物(002166.SZ)控制权或将易手 12月10日起停牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2590101733","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590101733?lang=zh_cn&edition=full","pubTime":"2025-12-09 19:04","pubTimestamp":1765278293,"startTime":"0","endTime":"0","summary":"智通财经APP讯，莱茵生物(002166.SZ)公告，公司于2025年12月8日收到控股股东、实际控制人秦本军先生的通知，秦本军先生正在筹划公司控制权变更事宜，拟向交易对手方协议转让其持有的部分公司股份并放弃其持有的部分公司股份表决权。目前相关各方已就该事项签署了《控制权变更意向协议》。公司股票自2025年12月10日开市起停牌，预计停牌时间不超过10个交易日。此外，公司拟以发行股份及支付现金方式购买北京金康普食品科技有限公司(简称“北京金康普”)至少80%股权，同时向广州德福营养发行股份募集配套资金。本次交易完成后，北京金康普将成为公司的控股子公司，纳入合并财务报表范围。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1379473.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"莱茵生物(002166.SZ)控制权或将易手 12月10日起停牌","news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002166","BK0239","BK0174","BK0168","BK0046","BK0028"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1777532076420,"stockEarnings":[{"period":"1week","weight":-0.0138},{"period":"1month","weight":-0.037},{"period":"3month","weight":-0.0763},{"period":"6month","weight":0.0618},{"period":"1year","weight":0.1783},{"period":"ytd","weight":0.0166}],"compareEarnings":[{"period":"1week","weight":0.0003},{"period":"1month","weight":0.047},{"period":"3month","weight":-0.0121},{"period":"6month","weight":0.0386},{"period":"1year","weight":0.2498},{"period":"ytd","weight":0.0349}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"桂林莱茵生物科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"39042人(较上一季度减少4.05%)","perCapita":"18917股","listingDate":"2007-09-13","address":"广西壮族自治区桂林市临桂区人民南路19号","registeredCapital":"74160万元","survey":" 桂林莱茵生物科技股份有限公司的主营业务是植物功能性成分的研发与生产。公司的主要产品是罗汉果提取物、甜叶菊提取物、茶叶提取物及其他植物提取物，瑞鲍迪苷RM2及甜菊糖苷RM系列产品、左旋β-半乳葡聚糖等。","listedPrice":9.89},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"莱茵生物(002166)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供莱茵生物(002166)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"莱茵生物,002166,莱茵生物股票,莱茵生物股票老虎,莱茵生物股票老虎国际,莱茵生物行情,莱茵生物股票行情,莱茵生物股价,莱茵生物股市,莱茵生物股票价格,莱茵生物股票交易,莱茵生物股票购买,莱茵生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"莱茵生物(002166)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供莱茵生物(002166)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}